Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Nanomedicine. 2020 May 30;28:102225. doi: 10.1016/j.nano.2020.102225

Figure 3.

Figure 3.

Percent uptake of PF-lip, PFTf-lip, R9F2-lip and R9F2Tf-liposomes in (A) bEnd.3, (B) glial and (C) primary neuronal cells after 0.1, 0.25, 0.5, 1 and 4 h of incubation. Percent uptake of PF-lip, PFTf-lip, R9F2-lip and R9F2Tf-liposomes after 4 h of incubation in (D) bEnd.3, (E) glial and (F) primary neuronal cells pretreated with endocytosis inhibitors (sodium azide, chlorpromazine, amiloride and colchicine). Data are expressed as mean ± SD (n=5).